News | Breast Density | March 06, 2019

South Dakota's Density Inform Bill Signed Into Law

South Dakota becomes 37th state with active breast density inform legislation

South Dakota's Density Inform Bill Signed Into Law

March 6, 2019 – With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which was signed on March 5, 2019 by Gov. Kristi Noem, goes into effect July 1, 2019.

South Dakota Rep. Taffy Howard introduced the legislation after becoming alarmed about the inconsistency of density notification across the state and the lack of information about the risks associated with dense breasts.

“Breast density is a critical piece of information regarding a woman’s breast health, but women are reliant upon their healthcare provider for this information, which is why this legislation was so vital. Many women across this state are informed by their provider about their breast density, but not all. This bill ensures all women across South Dakota are informed as to their breast density. It will also provide additional information if they are in one of the two higher levels of density and encourage women to discuss findings with their primary care providers,” said Howard.

Approximately 40 percent of women aged 40 and over have dense breast tissue that may hide cancers on mammography. Women with dense breasts may benefit from supplemental screening tests, in addition to mammography, to detect cancers. Women with extremely dense breasts are also 4-6 times more likely to develop breast cancer than women with the least dense breasts. Providing women with their breast density classification would enable them to initiate discussions with their physicians about whether supplemental screening might be beneficial.

“Sen. Deb Soholt was tremendously helpful in getting key players on board,” continued Howard. “I am tremendously grateful to JoAnn Pushkin, executive director of DenseBreast-info.org for all her hard work in calling attention to this issue and, along with Jill Schultz, with Avera Breast Center, for providing outstanding testimony in support of the bill. We all have an obligation to fight this disease in whatever way we are able, and I was glad to be able to aid in a small way in that fight.”                    

South Dakota’s state law follows the Feb. 15, 2019 passage of federal legislation directing the U.S. Food and Drug Administration (FDA), through the regulatory process, to develop reporting language and ensure that mammography reports and summaries received by patients and their providers include appropriate information about breast density. The timeline for implementation of federally mandated reporting language is unknown; however, once the new standard is introduced, individual state law review will be necessary.

Read the article "Congress Directs FDA to Establish Federal Breast Density Inform Standard"

For more information: www.densebreast-info.org

Related Content

Researchers developed a deep learning model that identifies imaging biomarkers to predict a patient’s risk for developing breast cancer

A deep learning model was developed that combined imaging and traditional risk factors.

News | Mammography | November 30, 2020
November 30, 2020 — Researchers at Massachusetts General Hospi...
 Lunit, a leading medical AI software company, will be joining the 106th Radiological Society of North America (RSNA) this year, presenting its AI solutions for chest X-ray and mammography at partner booths.
News | Artificial Intelligence | November 24, 2020
November 24, 2020 — Lunit, a leading medical AI software company, will be joining the 106th...
ProFound AI for DBT offers superior clinical performance when compared to other commercially available breast AI systems
News | Breast Imaging | November 24, 2020
November 24, 2020 — iCAD reported that over 1,000 licenses have been sold as part of...
Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening, announced its partnership with Mammography Educators to offer the first artificial intelligence powered telehealth technologist training platform to support business continuity in mammography facilities.
News | Mammography | November 20, 2020
November 20, 2020 — Densitas Inc., a global provider of A.I.
Radiologists around the world will have access to a first-of-its-kind online breast density training tool designed to improve radiologists' ability to correctly identify women's breast density categories to comply with the Breast Imaging-Reporting and Data System (BI-RADS), thanks to a collaboration between DetectED-X and Volpara Health. 
News | Breast Density | November 19, 2020
November 19, 2020 — Radiologists around the world will have access to a first-of-its-kind online...
Reduces the complexity of reporting for screening and diagnostic MRI eams to deliver time-saving and patient safety benefits
News | MRI Breast | November 18, 2020
November 18, 2020 — ...
An interview with Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, on the effects on breast imaging in the COVID-19 era

Getty Images

Feature | Breast Imaging | November 12, 2020 | By Dave Fornell
The pandemic forced many elective procedures, including most areas of...
Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single

Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single-slice DBT image in craniocaudal view. C, Magnification of the lesion depicted in B. D, Image from SM in mediolateral oblique view. E, Single-slice DBT image in mediolateral oblique view. F, Magnification of the lesion depicted in E. Images courtesy of Radiological Society of North America

News | Breast Imaging | November 11, 2020
November 11, 2020 — ...